Deutsche Bank Downgrades Ligand Pharmaceuticals To Hold

Analysts at Deutsche Bank downgraded Ligand Pharmaceuticals Inc. LGND from Buy to Hold. Ligand Pharmaceuticals shares have gained 44.75 percent over the past 52 weeks, while the S&P 500 index has surged 8.07 percent in the same period. Ligand Pharmaceuticals' shares fell 0.24 percent to close at $93.93 on Friday.